These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7447417)

  • 1. Enhancement of activity against influenza viruses by combinations of antiviral agents.
    Hayden FG; Douglas RG; Simons R
    Antimicrob Agents Chemother; 1980 Oct; 18(4):536-41. PubMed ID: 7447417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque inhibition assay for drug susceptibility testing of influenza viruses.
    Hayden FG; Cote KM; Douglas RG
    Antimicrob Agents Chemother; 1980 May; 17(5):865-70. PubMed ID: 7396473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative potencies of anti-influenza compounds.
    Tisdale M; Bauer DJ
    Ann N Y Acad Sci; 1977 Mar; 284():254-63. PubMed ID: 280137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents].
    Boreko EI; Pavlova NI; Votiakov VI
    Vopr Virusol; 1999; 44(3):115-9. PubMed ID: 10392434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined interferon-alpha 2, rimantadine hydrochloride, and ribavirin inhibition of influenza virus replication in vitro.
    Hayden FG; Schlepushkin AN; Pushkarskaya NL
    Antimicrob Agents Chemother; 1984 Jan; 25(1):53-7. PubMed ID: 6703684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the antiviral activity of Russian anti-influenza agents in cell culture and animal models].
    Leneva IA; Fediakina IT; Eropkin MIu; Gudova NV; Romanovskaia AA; Danilenko DM; Vinogradova SM; Lepeshkin AIu; Shestopalov AM
    Vopr Virusol; 2010; 55(3):19-27. PubMed ID: 20608077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.
    Nguyen JT; Hoopes JD; Smee DF; Prichard MN; Driebe EM; Engelthaler DM; Le MH; Keim PS; Spence RP; Went GT
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4115-26. PubMed ID: 19620324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice.
    Galabov AS; Simeonova L; Gegova G
    Antivir Chem Chemother; 2006; 17(5):251-8. PubMed ID: 17176629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of ribavirin and ozeltamivir effectively inhibits reproduction of influenza A virus resistant to rimantadine (amantadine) in vitro and in vivo.
    Deryabin PG; Galegov GA; Konstantinova ID; Muzyka IS; Miroshnikov AI; L'vov DK
    Dokl Biochem Biophys; 2014 Mar; 455(1):80-3. PubMed ID: 24795106
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium.
    Hayden FG; Rollins BS; Madren LK
    Antiviral Res; 1994 Oct; 25(2):123-31. PubMed ID: 7847874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-influenza virus activity of the compound LY253963.
    Hayden FG; Rollins BS; Hay AJ
    Antiviral Res; 1990 Jul; 14(1):25-38. PubMed ID: 2080866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antiviral substances against influenza A virus strains by the haemadsorption reduction test.
    Heider H; Adamczyk B; Richter B
    Acta Virol; 1980 Sep; 24(5):373-6. PubMed ID: 6108069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.
    Smee DF; Morrison AC; Barnard DL; Sidwell RW
    J Virol Methods; 2002 Oct; 106(1):71-9. PubMed ID: 12367731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses.
    Checkmahomed L; Padey B; Pizzorno A; Terrier O; Rosa-Calatrava M; Abed Y; Baz M; Boivin G
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33049959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adamantan derivatives capable of inhibiting the reproduction of a Rimantadine resistant strain of influenza A(H1N1)pdm09 virus (Influenza A virus, Alphainfluenzavirus, Orthomyxoviridae).].
    Garaev TM; Odnovorov AI; Kirillova ES; Burtseva EI; Finogenova MP; Mukasheva EA; Grebennikova TV
    Vopr Virusol; 2020; 65(1):16-20. PubMed ID: 32496716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo activities of anti-influenza virus compound T-705.
    Furuta Y; Takahashi K; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Watanabe Y; Narita H; Shiraki K
    Antimicrob Agents Chemother; 2002 Apr; 46(4):977-81. PubMed ID: 11897578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of amantadine-resistant influenza A (H1N1 pdm09) virus isolated from slum dwellers of Dhaka, Bangladesh.
    Rahman M; Hoque SA; Islam MA; Rahman SR
    Virus Genes; 2017 Jun; 53(3):377-385. PubMed ID: 28401407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro effects of antiviral drugs on the reproduction of highly pathogenic influenza A/H5N1 virus strains that induce epizooty among poultry in the summer of 2005].
    L'vov DK; Fediakina IT; Shchelkanov MIu; Prilipov AG; Deriabin PG; Galegov GA
    Vopr Virusol; 2006; 51(2):20-2. PubMed ID: 16756173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New betulin derivatives in combination with rimantadine for inhibition of influenza virus reproduction].
    Savinova OV; Pavlova NI; Boreko EI
    Antibiot Khimioter; 2009; 54(5-6):16-20. PubMed ID: 20052912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
    Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
    Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.